Sie sind auf Seite 1von 2

POLYTECHNIC COLLEGE OF DAVAO DEL SUR, INC.

MacArthur Highway, Digos City

DRUG STUDY
DATE/TI
ME
ORDERE
D

BRAND
NAME

fetusin

GENERI
C
NAME
oxytoci
n

CLASSIF
ICATION
Hormon
es

ACTION

INDICATI
ON

ROUTE/DOS
AGE/
TIME
INTERVAL

Stimulates
the
contractio
n of
smooth
muscle in
the uterus
and alveoli
of the
lactating
breast. At
coitus,
uterine
stimulatio
n by
oxytocin
causes
peristaltic
activity
that
assists the
migration
of
spermatoz
oa. During
parturition
, the
hormone
enhances
the
uterine
contractio
ns.

Is used in
antepartu
m when
an early
vaginal
delivery is
desired. It
is the
drug of
choice for
the
maintenan
ce of labor
once the
pregnancy
is at term
and used
frequently
when
there is
prolonged
uterine
inertia
than when
labor is
only
somewhat
sluggish.

Injection 10
units/mL

HALF LIFE
IM is 2 to 3
h. IV is 1 h.

ABSORPTIO
N
Wellabsorbed

DRUG
INTERACTION

ADVERSE
EFFECT

PRECAUTION
CONTRAINDICA
TIONS

NURSING
RESPONSIB
ILITES

Cyclopropane
anesthesia:
maternal
hypotension,
bradycardia, and
abnormal AV
rhythms.
Vasoconstrictors/C
auda:l block
anesthesia
Severe
hypertension
following
prophylactic
administration of a
vasoconstrictor in
conjunction with
caudal block
anesthesia.
Incompatibility:
Sodium
bicarbonate.
rapidly
decomposed in
the presence of
sodium bisulfite.
EXCRETION
Small amounts are
unchanged in the
urine. The t of
plasma is 1 to 6
min.

CV:Hypertention,incr
ease heart
rate,systemic
venous
returns,cardiac
output
GI:Nausea and
Vomiting
Repiratory:Anoxia,A
sphyxia
Others:Low APGAR
score at 5 mins.

Hypersensitivity to
the drug;
significant
cephalopelvic
disproportion;
inadequate,
undeliverable fetal
position; obstetric
emergencies in
which surgical
intervention is
preferred; cases
of fetal distress in
which delivery is
not imminent;
prolonged use in
uterine inertia or
severe toxemia;
hypertonic or
hyperactive
uterine patterns;
when adequate
uterine activity
fails to achieve
satisfactory
response; when
vaginal delivery is
contraindicated

Start flow
charts to
record
maternal BP
and other vital
signs, I&O
ratio, weight,
strength,
duration, and
frequency of
contractions,
as well as
fetal heart
tone and rate,
before
instituting
treatment.
Monitor fetal
heart rate and
maternal BP
and pulse at
least q15min
during
infusion
period;
evaluate
tonus of
myometrium
during and
between
contractions
and record on
flow chart.
Report change
in rate and

rhythm
immediately.

Name:
Mary Shan Padilla Section & Year: BSN 2
Reference: Lipincotts Nursing Drug Guide

Rating: __________

Criteria:

Content (45%)
_________
Nursing Responsibilities (35%) _________
Clinical Instructor: Ms. Lesley Ann Miro-Pascual, RN,

MAN

Promptness (5%) _________


Format/Neatness (5%)
_________
Illustration (10%) _________